Management of Hypertension and Diabetes in Geriatric Patients

Patient Stratification and Management

• For geriatric patients with hypertension and diabetes, the American Diabetes Association recommends stratifying management based on health status: target A1C <7.5% and BP <140/90 mmHg for healthy older adults, while relaxing to A1C <8.0-8.5% and BP <150/90 mmHg for those with multiple comorbidities or functional impairment, prioritizing avoidance of hypoglycemia and hypotension over tight control 1, 2
• The American Diabetes Association suggests classifying geriatric patients into three categories to guide treatment intensity: healthy older adults, complex/intermediate health status, and very complex/poor health 1, 2
• For healthy older adults, the American Diabetes Association recommends a glycemic target of A1C <7.5% and a blood pressure target of <140/90 mmHg, with a rationale of longer remaining life expectancy justifying more aggressive control to prevent microvascular complications 1, 2
• For patients with complex/intermediate health status, the American Diabetes Association recommends a glycemic target of A1C <8.0% and a blood pressure target of <140/90 mmHg, with a rationale of intermediate life expectancy with high treatment burden and increased hypoglycemia vulnerability 1, 2
• For patients with very complex/poor health, the American Diabetes Association recommends a glycemic target of A1C <8.5% and a blood pressure target of <150/90 mmHg, with a rationale of limited life expectancy making aggressive treatment benefit uncertain while harm from hypoglycemia/hypotension is substantial 1, 2

Hypertension Management

• The American Heart Association recommends targeting systolic BP <140 mmHg for patients <80 years, and 140-145 mmHg if tolerated for patients ≥80 years, with a critical caveat to maintain diastolic BP >70-75 mmHg in patients with coronary heart disease to prevent reduced coronary perfusion 3, 4
• The American Heart Association suggests avoiding systolic BP <120 mmHg, which shows potential harm without additional cardiovascular benefit in older diabetics 4
• The American Heart Association recommends a pharmacological approach of starting low and going slow due to age-related changes in drug metabolism, with first-line agents including ACE inhibitors or ARBs, thiazide diuretics, and calcium channel blockers 1, 5

Diabetes Management

• The American Diabetes Association recommends selecting medications with low hypoglycemia risk, with metformin as the first-line agent for type 2 diabetes, and adding agents that reduce cardiovascular and kidney disease risk regardless of glycemic control for patients with established ASCVD, heart failure, or CKD 1, 6
• The American Diabetes Association suggests avoiding or deintensifying sulfonylureas, meglitinides, and complex insulin regimens in patients with functional limitations 1, 6
• The American Diabetes Association recommends basal insulin once daily as a reasonable option for most older patients with minimal side effects, and titrating to meet individualized glycemic targets while avoiding hypoglycemia 6

Cardiovascular Risk Factor Management

• The American Heart Association recommends comprehensive cardiovascular risk management, including statin therapy for patients with life expectancy ≥2.5 years, and targeting LDL-C <100 mg/dL for those with ≥1 major CVD risk factor 1, 5, 8
• The American Heart Association suggests aspirin therapy for secondary prevention in patients with known cardiovascular disease, and using with caution in those ≥80 years for primary prevention 4

Lifestyle Interventions

• The American Diabetes Association recommends aerobic activity and resistance training in all who can safely participate, and optimal protein intake to prevent sarcopenia and frailty 1, 8
• The American Diabetes Association suggests intensive lifestyle intervention for overweight/obese patients capable of safe exercise, targeting 5-7% weight loss through dietary changes and physical activity 8

Critical Pitfalls to Avoid

• The American Diabetes Association recommends avoiding overtreatment, regularly reassessing treatment intensity, and simplifying complex regimens when possible 1, 6
• The American Diabetes Association suggests preventing hypoglycemia by checking for high-risk factors, assessing at every visit, and adjusting medications accordingly 7, 9
• The American Heart Association recommends avoiding orthostatic hypotension, excessive diastolic lowering, and gradual titration to avoid complications 2, 5